Marta Batus to Antineoplastic Agents
This is a "connection" page, showing publications Marta Batus has written about Antineoplastic Agents.
Connection Strength
1.313
-
Marta Batus on the New Direct-to-Consumer Advertising for Nivolumab, and Its Impact on Oncology Practice. Oncology (Williston Park). 2016 Jun; 30(6):506, 523.
Score: 0.448
-
Future directions for pediatric and young adult bone sarcoma. Curr Probl Cancer. 2013 Jul-Aug; 37(4):225-35.
Score: 0.366
-
Optimal management of metastatic melanoma: current strategies and future directions. Am J Clin Dermatol. 2013 Jun; 14(3):179-94.
Score: 0.364
-
Neoadjuvant treatment of rectal gastrointestinal stromal tumors with imatinib. Am Surg. 2010 Aug; 76(8):E110-2.
Score: 0.075
-
Effects of ERBB2 amplicon size and genomic alterations of chromosomes 1, 3, and 10 on patient response to trastuzumab in metastatic breast cancer. Genes Chromosomes Cancer. 2007 Apr; 46(4):397-405.
Score: 0.059